Form 8-K - Current report:
SEC Accession No. 0001104659-24-009012
Filing Date
2024-02-01
Accepted
2024-01-31 21:18:44
Documents
14
Period of Report
2024-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244837d1_8k.htm   iXBRL 8-K 25040
  Complete submission text file 0001104659-24-009012.txt   197972

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA immu-20240131.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20240131_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20240131_pre.xml EX-101.PRE 22359
15 EXTRACTED XBRL INSTANCE DOCUMENT tm244837d1_8k_htm.xml XML 3611
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 24584765
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)